AOD 9604 ZPHC — 12.5 mg (5 vials × 2.5 mg)

AOD 9604 — targeted fat-loss peptide
5 lyophilised vials × 2.5 mg (total 12.5 mg)
Mechanism: fragment 176-191 analogue that boosts lipolysis and blocks lipogenesis without raising IGF-1 or blood glucose.
Reconstitution: add 1 ml bacteriostatic water → 2.5 mg/ml; swirl gently, do not shake.
Storage: refrigerate 2 – 8 °C after mixing; freeze-dried powder ships safely at room temperature.
Sample research dosing: 250 – 500 µg sub-Q daily (split AM/PM) for 4 – 6 weeks.
QC: ≥ 99 % purity (HPLC); endotoxin < 0.03 EU/mg; scratch-code authenticity on every box.
Cold-chain packed • tamper-evident vials • discreet, tracked worldwide delivery., AOD 9604 ZPHC — 12.5 mg (5 vials × 2.5 mg), 59, USD, ,